109 related articles for article (PubMed ID: 2546384)
1. Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B4 antagonist U-75,302.
Taylor BM; Czuk CI; Brunden MN; Wishka DG; Morris J; Sun FF
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():195-8. PubMed ID: 2546384
[No Abstract] [Full Text] [Related]
2. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
Palmblad J; Udén AM; Friberg I; Ringertz B; Rådmark O; Lindgren JA; Hansson G; Malmsten CL
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():25-31. PubMed ID: 6303087
[No Abstract] [Full Text] [Related]
3. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.
Muñoz NM; Douglas I; Mayer D; Herrnreiter A; Zhu X; Leff AR
Am J Respir Crit Care Med; 1997 Apr; 155(4):1398-403. PubMed ID: 9105085
[TBL] [Abstract][Full Text] [Related]
4. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
McEwen BJ; Wilcock BP; Eyre P
Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of leukotriene B4 analogs: inhibition of guinea pig eosinophil migration in vitro by the 2,6-disubstituted pyridine analogs U-75,302 and U-75,485.
Taylor BM; Crittenden NJ; Bruden MN; Wishka DG; Morris J; Richards IM; Sun FF
Prostaglandins; 1991 Sep; 42(3):211-24. PubMed ID: 1664113
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
9. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
10. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists.
Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ
Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282
[TBL] [Abstract][Full Text] [Related]
11. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
Schleimer RP; Freeland HS; Peters SP; Brown KE; Derse CP
J Pharmacol Exp Ther; 1989 Aug; 250(2):598-605. PubMed ID: 2547940
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic effects of leukotriene B4 in the microcirculation.
Nagai K; Katori M
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():905-7. PubMed ID: 2823577
[No Abstract] [Full Text] [Related]
13. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
14. Effect of BRL-35135 on LTB4-induced guinea pig eosinophil chemotaxis.
Sugasawa T; Morooka S
Agents Actions; 1992 Nov; 37(3-4):232-7. PubMed ID: 1363505
[TBL] [Abstract][Full Text] [Related]
15. Effects of ZCR-2060 on allergic airway inflammation and cell activation in guinea-pigs.
Abe T; Yoshida K; Omata T; Segawa Y; Matsuda K; Nagai H
J Pharm Pharmacol; 1994 Nov; 46(11):876-82. PubMed ID: 7897591
[TBL] [Abstract][Full Text] [Related]
16. New method for the measurement of eosinophil migration.
Håkansson L; Westerlund D; Venge P
J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
Iwamoto I; Tomoe S; Tomioka H; Yoshida S
J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
[TBL] [Abstract][Full Text] [Related]
18. The effect of eosinophil chemotactic factors on in vitro eosinopoiesis in the guinea pig.
Czarnetzki BM; Pawelzik B
Blut; 1983 Nov; 47(5):287-96. PubMed ID: 6313099
[TBL] [Abstract][Full Text] [Related]
19. Optical isomers of a leukotriene B4 antagonist have differential effects on granulocyte diapedesis in the guinea pig dermis.
Fretland DJ; Widomski DL; Anglin CP; Yu S; Djuric SW
Chirality; 1992; 4(6):353-5. PubMed ID: 1333259
[TBL] [Abstract][Full Text] [Related]
20. Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan.
Bruynzeel PL; Kok PT; Hamelink ML; Kijne AM; Verhagen J
FEBS Lett; 1985 Sep; 189(2):350-4. PubMed ID: 2995125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
